StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1035
This month
17
This week
4
This year
110
Yesterday
1
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Sector
Commercial services
8
Communications
8
Consumer durables
5
Consumer non-durables
16
Consumer services
2
Distribution services
4
Electronic technology
18
Finance
5
Health care and social assistance
1
Health services
16
Health technology
1035
Industrial services
1
Information
4
Manufacturing
136
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
13
Producer manufacturing
16
Professional, scientific, and technical services
18
Retail trade
3
Technology services
16
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
86
Earnings
18
Europe
15
Expansion
11
Expected
35
Eye
15
Fda
23
Financial
24
Global
228
Growing
43
Growth
236
Health
19
Immunotherapy
11
Infection
9
Key
9
Kisqali
11
Leukemia
10
Liver
11
Market
593
N/a
949
Novartis
135
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
16
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
10
Sclerosis
13
Set
16
Study
15
T-cell
11
Technology
12
Therapeutics
110
Therapy
65
Treatment
114
Trial
16
Update
10
Vaccine
10
Year
12
Entities
3m company
8
Abbott laboratories
106
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
172
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
265
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
13
Novartis ag
1035
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
285
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
AAPL
1198
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1797
ACN
602
AMGN
744
ARVL
4323
AVGO
597
AZN
668
BDX
796
BMY
664
BNPQF
1769
BNPQY
1769
CSCO
900
DHR
786
ERIC
1617
F
643
FNCTF
7232
FRBA
602
GE
919
GLAXF
661
GOOG
1297
GOOGL
1296
GSK
887
HON
1794
HUBS
1400
IBM
658
INTC
956
IT
595
JNJ
4608
LLY
1712
LTUM
973
LYV
717
MDT
1286
MMM
938
MS
4300
MSFT
1206
MT
594
NOK
917
NOKBF
993
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1133
PPRUY
1134
SAP
1481
SAPGF
1235
SNOW
796
SNY
4566
SNYNF
3624
TEVJF
633
TMO
1630
VZ
1224
XYF
679
Exchanges
Amex
6
Nasdaq
1035
Nyse
1035
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
6
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
4
2021 - 10 - 20
3
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Crawled Time
00:00
43
00:20
9
01:00
44
02:00
25
03:00
32
04:00
18
04:20
8
05:00
25
06:00
59
07:00
34
08:00
28
08:20
4
09:00
40
10:00
29
11:00
44
11:01
1
12:00
68
12:20
14
12:30
8
13:00
25
13:15
2
13:20
7
13:30
4
14:00
34
14:15
1
14:20
10
14:30
7
14:49
1
15:00
39
15:15
1
15:20
16
15:30
14
16:00
50
16:20
3
17:00
49
18:00
49
19:00
43
20:00
35
20:20
3
21:00
26
22:00
43
23:00
40
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
www.biospace.com
86
www.globenewswire.com
176
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
765
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvsef
save search
Novartis Completes Acquisition of Chinook Therapeutics
Published:
2023-08-11
(Crawled : 15:20)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
11.13%
|
O:
0.81%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.78%
|
O:
-0.27%
H:
0.78%
C:
0.56%
acquisition
novartis
therapeutics
Environmental Factors and Advancements in Immunotherapies Propel Growth of Global Allergy Treatment Market to 2027
Published:
2023-08-10
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
13.62%
|
O:
0.63%
H:
0.0%
C:
-2.67%
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
13.78%
|
O:
2.5%
H:
0.0%
C:
-0.11%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.84%
|
O:
0.13%
H:
0.72%
C:
-0.18%
JNJ
|
News
|
$147.46
-0.72%
820K
|
Health Technology
|
-14.23%
|
O:
0.75%
H:
1.13%
C:
-1.05%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
16.15%
|
O:
0.0%
H:
0.61%
C:
-0.28%
BHC
|
$8.465
-1.11%
93K
|
Health Technology
|
-0.7%
|
O:
-0.23%
H:
1.22%
C:
-2.21%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
11.43%
|
O:
0.41%
H:
1.08%
C:
0.16%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-9.87%
|
O:
1.52%
H:
1.05%
C:
0.47%
propel
treatment
global
growth
market
Blockchain technology in the healthcare market to grow by USD 1,939.31 million from 2022 to 2027; The growing inclination toward data security to boost the market - Technavio
Published:
2023-08-09
(Crawled : 00:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
13.78%
|
O:
2.5%
H:
0.0%
C:
-0.11%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.84%
|
O:
0.13%
H:
0.72%
C:
-0.18%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-9.87%
|
O:
1.52%
H:
1.05%
C:
0.47%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
4.93%
|
O:
0.52%
H:
1.24%
C:
0.2%
blockchain
security
growing
technology
market
CAR T-Cell Therapy Market size to grow at a CAGR of 13.44% from 2022 to 2027; Growing Awareness Regarding CAR T-cell Therapy to boost the market growth- Technavio.
Published:
2023-08-09
(Crawled : 08:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
15.8%
|
O:
1.92%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.56%
|
O:
-0.07%
H:
0.73%
C:
0.36%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
16.81%
|
O:
0.14%
H:
0.8%
C:
0.43%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
-16.23%
|
O:
0.61%
H:
1.07%
C:
-0.5%
AUTL
|
$4.105
-2.49%
770K
|
Health Technology
|
41.75%
|
O:
-2.02%
H:
3.44%
C:
2.75%
t-cell
growing
therapy
market
Dry Eye Syndrome Drugs Market to grow by USD 2,159.21 million from 2022 to 2027; The growing geriatric population drives the market - Technavio
Published:
2023-08-09
(Crawled : 08:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
15.8%
|
O:
1.92%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
VTRS
|
News
A
|
$11.585
0.3%
150K
|
Health Technology
|
3.59%
|
O:
0.0%
H:
2.96%
C:
0.99%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.56%
|
O:
-0.07%
H:
0.73%
C:
0.36%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
16.81%
|
O:
0.14%
H:
0.8%
C:
0.43%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
11.26%
|
O:
-0.16%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.76
-0.12%
150K
|
Health Technology
|
-0.39%
|
O:
-1.71%
H:
0.0%
C:
0.0%
growing
eye
market
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticaria
Published:
2023-08-09
(Crawled : 06:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.56%
|
O:
-0.07%
H:
0.73%
C:
0.36%
urticaria
rapid
control
trials
novartis
Antithrombotic drugs market size to grow by USD 23,199.94 million from 2022 to 2027: The growing prevalence of coagulation disorders drives growth - Technavio
Published:
2023-08-09
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
15.8%
|
O:
1.92%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
VTRS
|
News
A
|
$11.585
0.3%
150K
|
Health Technology
|
3.59%
|
O:
0.0%
H:
2.96%
C:
0.99%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.56%
|
O:
-0.07%
H:
0.73%
C:
0.36%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
16.81%
|
O:
0.14%
H:
0.8%
C:
0.43%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
11.26%
|
O:
-0.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-9.14%
|
O:
0.81%
H:
0.0%
C:
0.0%
AZN
|
News
|
$75.37
5.86%
2.7M
|
Health Technology
|
2.06%
|
O:
1.61%
H:
0.95%
C:
0.55%
disorders
growing
growth
market
North America Kidney Transplant Research Report 2023
Published:
2023-08-08
(Crawled : 22:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
ALPMY
|
News
|
$9.47
400K
|
Manufacturing
|
-36.91%
|
O:
3.93%
H:
0.0%
C:
-3.08%
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-26.29%
|
O:
-0.11%
H:
1.29%
C:
0.67%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.56%
|
O:
-0.07%
H:
0.73%
C:
0.36%
MDT
|
$79.69
-0.86%
400K
|
Health Technology
|
-4.23%
|
O:
-1.98%
H:
1.7%
C:
0.81%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-9.14%
|
O:
0.81%
H:
0.0%
C:
0.0%
america
report
kidney
research
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published:
2023-08-04
(Crawled : 12:20)
- precisionbiosciences.com
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-3.62%
|
O:
-0.38%
H:
0.73%
C:
0.15%
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
66.62%
|
O:
-0.53%
H:
0.0%
C:
0.0%
DTIL
|
$9.82
3.3K
|
Health Technology
|
1653.88%
|
O:
-0.95%
H:
0.0%
C:
0.0%
business
update
financial
results
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Published:
2023-08-02
(Crawled : 20:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-4.28%
|
O:
-1.38%
H:
0.77%
C:
0.7%
RARE
F
|
$44.28
-1.84%
-1.92%
150
|
Health Technology
|
4.56%
|
O:
0.0%
H:
0.85%
C:
-2.48%
RGNX
|
$16.04
0.88%
0.93%
0
|
Health Technology
|
-15.13%
|
O:
-7.2%
H:
10.26%
C:
-0.34%
financial
results
The Worldwide Generic Drugs Market is Expected to Grow at a CAGR of over 6.51% During 2018-2028
Published:
2023-07-28
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
10.55%
|
O:
-2.63%
H:
2.59%
C:
1.75%
VTRS
|
News
A
|
$11.585
0.3%
150K
|
Health Technology
|
11.81%
|
O:
1.16%
H:
0.0%
C:
-0.48%
NVO
|
News
|
$126.16
-1.93%
-2.81%
100K
|
Health Technology
|
-19.47%
|
O:
-0.01%
H:
0.93%
C:
0.75%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-5.28%
|
O:
0.36%
H:
0.09%
C:
-0.02%
ABT
|
News
|
$106.76
-0.12%
150K
|
Health Technology
|
-6.59%
|
O:
-1.09%
H:
0.3%
C:
-0.4%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-11.4%
|
O:
-3.09%
H:
0.0%
C:
0.0%
expected
market
RNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technavio
Published:
2023-07-27
(Crawled : 08:00)
- prnewswire.com
RNAZ
|
$0.4399
-4.35%
-1.75%
1.9K
|
Professional, Scientific, and T...
|
-80.87%
|
O:
2.57%
H:
3.43%
C:
0.47%
TMO
|
News
|
$577.39
0.49%
430
|
Health Technology
|
0.52%
|
O:
0.17%
H:
0.35%
C:
-2.67%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-5.33%
|
O:
0.7%
H:
0.12%
C:
-0.76%
SLN
|
$22.27
-1.07%
-0.81%
0
|
Health Technology
|
315.49%
|
O:
2.61%
H:
0.27%
C:
-2.18%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-10.58%
|
O:
0.92%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$87.62
-0.53%
29K
|
Health Technology
|
-17.68%
|
O:
-0.64%
H:
0.0%
C:
0.0%
BNTC
|
$6.72
-2.04%
-1.63%
0
|
Health Technology
|
81.62%
|
O:
-8.92%
H:
9.49%
C:
0.59%
drug
report
market
Oncology Drugs Market to grow at a CAGR of 11.99% from 2022 to 2027. AbbVie Inc., Amgen Inc. & Apikos Pharma are major vendors - Technavio
Published:
2023-07-27
(Crawled : 05:00)
- prnewswire.com
ABBNY
|
News
|
$48.7
-0.37%
950
|
n/a
|
21.26%
|
O:
2.13%
H:
0.04%
C:
-1.67%
ABLZF
|
News
|
$49.574
2.46%
0
|
Producer Manufacturing
|
21.69%
|
O:
0.58%
H:
0.0%
C:
-0.46%
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
10.09%
|
O:
2.38%
H:
2.49%
C:
2.49%
ALPMY
|
News
|
$9.47
400K
|
Manufacturing
|
-36.53%
|
O:
3.75%
H:
0.0%
C:
-2.78%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-5.33%
|
O:
0.7%
H:
0.12%
C:
-0.76%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
13.91%
|
O:
1.03%
H:
0.39%
C:
-1.02%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
18.62%
|
O:
2.13%
H:
4.77%
C:
3.02%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-10.58%
|
O:
0.92%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
16.07%
|
O:
-0.31%
H:
1.71%
C:
0.67%
pharma
abbvie
market
Tyrosine Kinase Inhibitors Market size to grow by USD 24.12 billion from 2022 to 2027 | High target affinity and specificity of tyrosine kinase inhibitors boost the market growth - Technavio
Published:
2023-07-26
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
10.09%
|
O:
2.38%
H:
2.49%
C:
2.49%
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
-3.67%
|
O:
-0.04%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.585
0.3%
150K
|
Health Technology
|
10.21%
|
O:
-0.24%
H:
0.48%
C:
-1.2%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-5.33%
|
O:
0.7%
H:
0.12%
C:
-0.76%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
13.91%
|
O:
1.03%
H:
0.39%
C:
-1.02%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
18.62%
|
O:
2.13%
H:
4.77%
C:
3.02%
PBYI
|
$4.83
-5.85%
-5.99%
0
|
Health Technology
|
37.61%
|
O:
0.28%
H:
0.85%
C:
-1.99%
AZN
|
News
|
$75.37
5.86%
2.7M
|
Health Technology
|
4.03%
|
O:
0.42%
H:
0.55%
C:
-0.86%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
16.07%
|
O:
-0.31%
H:
1.71%
C:
0.67%
growth
market
Germany Pharmaceuticals Market size to grow by USD 21.44 billion from 2022 to 2027|The high investment in the pharmaceutical industry boosts market growth - Technavio
Published:
2023-07-26
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
12.46%
|
O:
1.5%
H:
0.64%
C:
0.64%
BABAF
|
News
|
$9.3
83K
|
Retail Trade
|
-22.15%
|
O:
2.54%
H:
0.65%
C:
0.65%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-6.17%
|
O:
-0.89%
H:
0.27%
C:
0.0%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
14.45%
|
O:
0.14%
H:
0.64%
C:
0.34%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
17.82%
|
O:
-0.67%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.76
-0.12%
150K
|
Health Technology
|
-5.38%
|
O:
-0.49%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-11.98%
|
O:
-1.57%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
16.02%
|
O:
-0.58%
H:
0.77%
C:
0.54%
germany
pharmaceuticals
growth
market
The Gastrointestinal OTC Drugs Market to grow by USD 4,759.86 million from 2022 to 2027|Increase in the prevalence of gastrointestinal disorders to boost the market- Technavio
Published:
2023-07-25
(Crawled : 04:00)
- prnewswire.com
HLN
|
$8.33
-0.24%
230K
|
n/a
|
-4.13%
|
O:
0.46%
H:
0.57%
C:
0.0%
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
9.91%
|
O:
-1.12%
H:
0.0%
C:
-1.16%
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
-14.11%
|
O:
-3.88%
H:
0.0%
C:
0.0%
PBH
|
$70.13
-1.53%
0.0%
0
|
Health Technology
|
11.34%
|
O:
-0.54%
H:
2.33%
C:
2.0%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-5.51%
|
O:
-0.64%
H:
1.58%
C:
1.35%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
14.36%
|
O:
-0.48%
H:
0.83%
C:
0.39%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
17.09%
|
O:
-0.62%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.76
-0.12%
150K
|
Health Technology
|
-5.96%
|
O:
-0.61%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-12.66%
|
O:
-0.76%
H:
0.0%
C:
0.0%
gastrointestinal
market
Global Eylea Market Sees Impressive Growth with Major Players Regeneron Pharmaceuticals, Bayer AG, and More Expanding Research and Development Efforts
Published:
2023-07-24
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
-14.11%
|
O:
-3.88%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.585
0.3%
150K
|
Health Technology
|
8.76%
|
O:
-0.66%
H:
0.43%
C:
-1.33%
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-5.51%
|
O:
-0.64%
H:
1.58%
C:
1.35%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-12.66%
|
O:
-0.76%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
24.67%
|
O:
-0.54%
H:
1.31%
C:
0.92%
eylea
research
global
growth
market
Sandoz receives positive CHMP opinion for multiple sclerosis biosimilar natalizumab
Published:
2023-07-24
(Crawled : 06:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
-6.34%
|
O:
-0.05%
H:
0.24%
C:
-0.83%
biosimilar
chmp
positive
sclerosis
Major Players Abbott, Pfizer, and Novartis Drive Growth in Global Hormone Therapy Market to 2032
Published:
2023-07-21
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.76
-0.12%
150K
|
Health Technology
|
Email alert
Add to watchlist
PRGO
|
$31.23
2.43%
0.0%
210
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
Email alert
Add to watchlist
global
novartis
therapy
growth
market
hormone
Major Players Merck & Co, Roche, and Pfizer Fuel Growth of Global 5-Alpha Reductase Deficiency Market to 2032
Published:
2023-07-21
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.32%
5.9K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
0.94%
0
|
Health Technology
|
Email alert
Add to watchlist
merck
global
growth
market
← Previous
1
2
…
10
11
12
13
14
15
16
17
18
…
51
52
Next →
Gainers vs Losers
49%
51%
Top 10 Gainers
CSSE
4
|
$0.299
96.32%
7M
|
Consumer Services
BRFH
4
|
$1.99
80.91%
13M
|
Manufacturing
LICN
|
$1.0
78.57%
3.3M
|
BOF
|
$1.915
63.68%
620K
|
MTC
|
$3.62
61.61%
790K
|
Technology Services
AMST
|
$3.13
56.5%
500K
|
Technology Services
ACON
|
$0.3595
24.83%
3.5M
|
n/a
ILAG
|
$0.669
23.89%
13M
|
CDTX
|
News
|
$14.57
18.55%
330K
|
Health Technology
MNY
|
$2.11
17.22%
180K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.